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Abstract
To study the individual functions of hyaluronan interacting proteins in prostate cancer (PCa) motility through connective
tissues, we developed a novel three-dimensional (3D) hyaluronic acid (HA) hydrogel assay that provides a flexible,
quantifiable, and physiologically relevant alternative to current methods. Invasion in this system reflects the prevalence of
HA in connective tissues and its role in the promotion of cancer cell motility and tissue invasion, making the system ideal to
study invasion through bone marrow or other HA-rich connective tissues. The bio-compatible cross-linking process we used
allows for direct encapsulation of cancer cells within the gel where they adopt a distinct, cluster-like morphology. Metastatic
PCa cells in these hydrogels develop fingerlike structures, ‘‘invadopodia’’, consistent with their invasive properties. The
number of invadopodia, as well as cluster size, shape, and convergence, can provide a quantifiable measure of invasive
potential. Among candidate hyaluronan interacting proteins that could be responsible for the behavior we observed, we
found that culture in the HA hydrogel triggers invasive PCa cells to differentially express and localize receptor for
hyaluronan mediated motility (RHAMM)/CD168 which, in the absence of CD44, appears to contribute to PCa motility and
invasion by interacting with the HA hydrogel components. PCa cell invasion through the HA hydrogel also was found to
depend on the activity of hyaluronidases. Studies shown here reveal that while hyaluronidase activity is necessary for
invadopodia and inter-connecting cluster formation, activity alone is not sufficient for acquisition of invasiveness to occur.
We therefore suggest that development of invasive behavior in 3D HA-based systems requires development of additional
cellular features, such as activation of motility associated pathways that regulate formation of invadopodia. Thus, we report
development of a 3D system amenable to dissection of biological processes associated with cancer cell motility through
HA-rich connective tissues.
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A majority of patients who die from solid tumors each year
suffer from bone metastases [1]. The three most commonly
diagnosed cancer types, prostate, lung, and breast, metastasize to
bone. Bone metastasis dramatically lowers quality of life due to
pain, fractures, and hypercalcemia [2]. Additionally, presence of
bone metastases lowers survival rates. For prostate cancer (PCa),
the five year survival rate for local disease is 100% while the rate
drops to 30% for advanced disease with distant metastases [1].
Currently, there are few effective therapies to treat bone metastasis
or to prevent metastasis to bone or other sites [2]. A defined
clinical need thus exists to develop new therapies to treat and
prevent bone metastasis involving motile, invasive cancer cells that
can readily colonize connective tissues such as bone marrow.
The study of pathways that control cancer cell invasion or
migration, and the development of new drug to prevent these
processes requires systems that can measure the invasive properties
of these cells [3,4]. Currently available invasion and migration
assays are less than ideal in that they often: 1) are difficult to
quantify, 2) are difficult to tailor to individual cancer cell
behaviors, or 3) employ matrices such as animal derived
MatrigelTM that contain growth factors that complicate experi-
mental results [3,5,6].
The bone marrow matrix consists of soft, gel-like connective
tissue rich in hyaluronic acid (HA) [7,8]. HA is a large, non-
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sulfated glycosaminoglycan comprised of repeating b-1,4-linked
D-glucuronic acid and b-1,3 N-acetyl-D-glucosamine disaccharide
units [9]. HA is found ubiquitously in the extracellular matrix
(ECM) of all cell types, but is particularly enriched in connective
tissues. Cells can bind HA through various receptors, including
cluster of differentiation 44 (CD44) or receptor for hyaluronan-
mediated motility (RHAMM) [10]. In cancer cells, RHAMM has
been shown to bind CD44 on the cell surface, and HA binding to
this complex promotes downstream signaling resulting in Rho
GTPase activation and increased cell migration [11,12]. Both
RHAMM and CD44 expression levels have been linked to
progression of a number of cancers, including PCa [13,14].
Another way that cells interact with HA is by degrading it, by
expression and secretion of hyaluronidases (HAases). Relevant to
PCa invasion are the HAases, Hyal-1 and Hyal-2, whose
expression levels have been implicated in PCa metastasis
[13,15,16]. Hyal-1 is active at low pHs from 3.5–3.8 and cleaves
any molecular weight HA into tetramers [17]. Hyal-2 shows
optimal activity at pH 6.0–7.0 and cleaves high molecular weight
HA into intermediate, 20 kDa size fragments [18]. A glycosylated,
57 kDa form of Hyal-1 can be secreted by cells [19]. HAase
secretion may facilitate PCa metastasis by allowing cancer cells to
invade the HA-rich connective tissue matrix.
Importantly, HAases are druggable targets, indicating their
potential use as targets to slow invasion and possibly prevent
metastasis [20,21]. One HAase inhibitor, disodium cromoglycate
(DSC) [22,23] is FDA approved for use to relieve symptoms of
allergy and asthma, and shows low toxicity in patients [24,25]. Its
ability to inhibit PCa invasion and metastasis has not been
investigated.
We previously described the development of a HA-based
hydrogel for culture of poorly adherent bone metastatic PCa cells
[26]. The hydrogel consists of two chemically modified HA
components, aldehyde-carrying HA (HAALD) and adipic acid
dihydrazide-derived HA (HAADH). These components crosslink
via the formation of hydrazine linkages, releasing water as the only
byproduct [27]. PCa cells can be encapsulated in the HA hydrogel
during the crosslinking process. Viability of the encapsulated cells
remains high for at least a week [26]. Because the HA is of
bacterial origin, it is devoid of eukaryotic growth factors that could
affect cell growth, invasion, and migration.
To study the development of invasive properties of PCa cells in
a native connective tissue matrix, we used the LNCaP series of
human PCa cell sublines that were developed to mimic the process
of PCa bone metastasis. These cells are regarded as one of the
better PCa progression models available because of their ability to
form clinically relevant osteoblastic lesions in mice [28]. Individual
sublines in the LNCaP series reflect the steps in disease progression
with LNCaP cells representing an early prostate tumor that has
reached a nearby lymph node, C4 cells representing aggressive,
locally invasive cancer cells that survive after castration, C4-2 cells
representing aggressive, metastatic disease, and C4-2B cells
representing PCa castration resistant bone metastases [29]. Using
these cells and the novel 3D HA gel invasion system we developed,
we investigated the role of HA receptors and HAases in PCa
invasion and migration through an HA-rich connective tissue like
matrix. For the purposes of this work describing the movement of
PCa cells in 3D hydrogels, which differs from migration across
plastic surfaces, we describe migration as the apparent movement
of cells through porous hydrogels evidenced by extension of
cellular processes we call ‘‘invadopodia’’ and by the merging of
formerly separated clusters in the hydrogels.
Materials and Methods
Materials
Electrophoresis, cell culture, and transfection reagents and
supplies were purchased from Invitrogen (Carlsbad, CA). TCMTM
defined serum replacement was purchased from MP Biomedicals
(Solon, OH). Hyaluronic acid (sodium salt, 500 KDa and
1.3 MDa) was generously donated by Genzyme Corporation
(Cambridge, MA). RHAMM (HMMR) and CD44 antibodies
were purchased from Novus Biologicals (Littleton, CO). Hyal2 and
b-actin antibody were purchased from Abcam (Cambridge, MA).
Equine-a-mouse-HRP secondary antibody was purchased from
Cell Signaling Technology (Danvers, MA). Hyal1 antibody,
bovine testicular hyaluronidase (BTH), b-mercaptoethanol
(bME), glycine, TweenH20, bovine serum albumin (BSA), sodium
formate, Coomassie brilliant blue, disodium cromoglycate (DSC),
and deoxycholic acid were purchased from Sigma Aldrich (St.
Louis, MO). Goat-a-rabbit-HRP secondary antibody, protease
inhibitors (PI), 5X sample buffer, sulfo-NHS-SS-biotin, and avidin
agarose were purchased from Thermo Scientific (Rockford, IL).
Laemmli sample buffer and alcian blue were purchased from
Biorad (Richmond, CA). Tris buffer, glacial acetic acid, methanol,
low melting point (LMP) agar, dimethyl sulfoxide (DMSO),
sodium dodecyl sulfate (SDS), Triton X-100, and sodium chloride
(NaCl) were purchased from Fisher Scientific (Fair Lawn, NJ).
Nonidet P-40 was purchased from Roche (Indianapolis, IL) and
ethanol was purchased from Decon Labs, Inc (King of Prussia,
PA). All compounds used were reagent grade or better.
Cell Culture
Low passage number PCa cells were maintained in Corning
(Lowell, MA) tissue culture 75 mm flasks at 37uC in 5.0% (v/v)
CO2 in T-medium supplemented with 5% (v/v) fetal bovine serum
(FBS) and 100 U/ml penicillin G sodium and 100 mg/ml
streptomycin sulfate in 0.085% (w/v) saline (PS). Medium was
changed every 2–3 days. Cells were passaged at approximately
80% confluency, judged by eye, using 0.25% (w/v) trypsin with
ethylenediaminetetraacetic acid (EDTA) 4NNa. LNCaP sublines
[30] were generously provided by Dr. Leland Chung and PC3
cells were purchased from ATCC (Manassas, VA).
Preparation of HAALD and HAADH
To synthesize the HA aldehyde (HAALD), oxidation reaction of
HA (1.3 MDa) was performed in the presence of sodium periodate
under aqueous conditions. Adipic dihydrazide (ADH)-modified
HA (HAADH) was synthesized by carbodiimide-mediated cou-
pling of ADH with the carboxyl groups of HA (500 KDa) in
aqueous conditions. Detailed procedures for the synthesis and
characterization of both of these HA derivatives was reported in
our previous study [26].
Cell Culture in 2D and 3D Conditions
HAALD and HAADH were dissolved separately in Dulbecco’s
phosphate buffered saline (DPBS) to a concentration of 10 mg/
mL overnight at 37uC. 2% (w/v) LMP agar in DPBS was prepared
and was melted in a 70uC heatblock (Labnet International,
Woodbridge, NJ) at least 1 hour prior to use. Dissolved HA
derivates were sterilized by UV irradiation at 254 nm for 15
minutes prior to use.
PCa cells were released from their flask using 0.25% (w/v)
Trypsin EDTA 4NA and the total number of cells was counted
using a hemocytometer (Hausser Scientific, Horsham, PA).
100,000 (for 24-well plate) or 600,000 (for 6-well plate) cells were
pelleted for each culture. Cell culture inserts (Millipore, Billerica,
Prostate Cancer Invadopodia in 3D HA Hydrogels
PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e50075
MA, pore size: 0.4 mm, diameter 12 mm for 24-well plate, 30 mm
for 6 well plate) were pre-wet in T-medium then placed in the
wells of a 24-well or 6-well culture plate (Beckton–Dickenson
Labware, Franklin Lakes, NJ). For 2D cultures, cell pellet was
mixed with T-medium (1 mL for 24-well plate, 4 mL for 6-well
plate) and plated.
For 3D HA hydrogel culture, cell pellet was mixed with 100 ml
(for 24-well plate) or 300 ml (for 6-well plate) of HAALD. An equal
volume of HAADH was added and the culture was mixed well to
evenly disperse cells. The hydrogel solution then was pipetted into
pre-wet cell culture inserts and allowed to solidify for approxi-
mately 10 minutes at 37uC. T-medium (1mL for 24-well plate,
4 mL for 6-well plate) supplemented with 1% (v/v) PS and either
5% (v/v) FBS or 2% (v/v) TCMTM was added around the insert
and the culture was incubated at 37uC, 5% (v/v) CO2. This
concentration of TCMTM is consistent with previous studies
supplementing C4-2 culture [31,32].
For 3D agar culture, cell pellet was mixed with 85 ml (for 24-
well plate) or 510 ml (for 6-well plate) DPBS warmed to 37uC. Pre-
melted 2% (w/v) LMP agar was added to DPBS/cell mixture to
a final concentration of 0.3% (w/v) LMP agar. Agar culture was
incubated at room temperature for approximately 5 minutes
before pipetting into the cell culture insert to prevent agar gel from
leaking through the membrane pores. Once plated in insert, the
agar gel was allowed to solidify for approximately 10 minutes at
room temperature. Solidification was performed at room temper-
ature to expedite gelation of soft agar. T-medium (1 mL for 24-
well plate, 4 mL for 6-well plate) was subsequently added around
the insert and the culture was incubated at 37uC, 5% (v/v) CO2.
For all cultures, half medium changes were performed every two
days.
Metabolic activity and cell counts were performed for the cell
types and culture conditions described. To measure metabolic
activity of cells, water soluble tetrazolium salt-1 (WST-1, Roche)
reagent was utilized as described [33] with the following
modifications: the assay was performed in a 24 well plate on cells
grown for either three or six days. WST-1 reagent (100 ml) was
applied to 1 mL culture medium and the plate was incubated at
37uC for 1 hour. After incubation, 100 ml of culture medium was
removed and placed in a 96 well plate. Absorbance was measured
at 450 nm in a DTX880 multimode detector (Beckman Coulter,
Brea, CA). To count cell numbers within the HA hydrogel, phase
contrast images were utilized. Within these images, an average-
sized cell cluster with clear cell boundaries was selected and the
number of cells in the cluster was counted. This number was
multiplied by the total number of clusters in the image, yielding an
approximate total cell count per photographed field.
Invasion Assay Quantification Methods
For all invasion assays, phase contrast images were taken of each
cell culture using a Nikon Eclipse TE2000-U (Tokyo, Japan)
microscope and a 10X objective. The average number of
invadopodia was determined by counting the total number of
invadopodia per photographed field for three biological replicates.
An ‘‘invadopodium’’ was defined as a thin cellular process
extending outward from a cell cluster, and clear enough to be
easily identified by eye. The percentage of merging clusters was
calculated by counting both the number of clusters in physical
contact with another cluster and the number of free clusters for
three biological replicates. From these values, the percentage of
merging clusters was calculated and considered an index of
migration in 3D hydrogels. In samples where networks of cell
clusters were observed, a single cell cluster was defined as a distinct,
rounded area of the cellular network sometimes appearing to
contain a higher cell density. For both types of quantification, care
was taken to ensure consistency when counts were being
performed.
Rheology
Rheological characterization of hydrogel samples were per-
formed on a stress-controlled rheometer (AR-G2, TA Instruments,
New Castle, DE) with a 20 mm diameter standard steel parallel-
plate geometry and at a 100 mm gap. Dynamic oscillatory time
sweeps were performed at 25uC or 37uC for agar and HA gels
respectively, and the storage (G‘) and loss (G‘‘) moduli were
recorded. 30 ml agar solution (0.3% w/v) or HAADH/HAALD
mixture (1% w/v) was loaded into the geometry that was
subsequently covered with mineral oil at the edge to prevent
water evaporation. These mixtures were allowed to solidify in situ
as the measurements were taken. Dynamic oscillatory time sweeps
were collected at angular frequencies of 6 rad/s and 1% strain
chosen from the linear viscoelastic regime [34]. These experiments
were repeated on at least three samples and averaged data are
presented.
Protein Extraction
The cells combined from two wells of a 6-well plate culture were
used for protein extraction experiments. BTH (180 ml at 10 mg/
mL) was applied and cultures were incubated at 37uC for 30
minutes. The cultures were transferred to centrifuge tubes and
cells were pelleted by centrifugation for 1 minute at 3000 RPM.
Cells were washed once with DPBS. Radioimmunoprecipitation
(RIPA) buffer (50 mM Tris buffer pH 8.0, 150 mM NaCl, 0.5%
(w/v) deoxycholic acid, 1% (v/v) Nonidet P-40, 0.1% (w/v) SDS,
ddH2O, 200 ml) containing PI was applied to the cell pellets.
Lysates were incubated on ice for 45 minutes with occasional
vortexing. Lysates were cleared by centrifugation at 13,000
rotations per minute (RPM) for 10 minutes. The total protein
concentration from the lysates was determined using a bicincho-
ninic acid (BCA) protein assay (Thermo Scientific) following
a standard protocol. Lysates were stored at 220uC.
Western Blotting
Protein (50 mg) was mixed with RIPA buffer and 5X Lane
Marker Sample Buffer and bME (3% (v/v) final) to a total volume
of 25 ml. Samples were boiled for 5 minutes, then cooled and
quickly spun. Samples and a protein ladder were electrophoresed
on a NUPAGE 4–12% Bis-Tris gel using an X-Cell SurelockTM
electrophoresis cell and MOPS running buffer. Samples were
transferred to a nitrocellulose membrane using an X-CellTM II
transfer apparatus and a transfer buffer consisting of 1.5125 mg/
mL Tris, 7.2 mg/mL glycine, and 0.01% (w/v) SDS at a setting of
21V for 1.5 hours.
The membrane was blocked in 3% (w/v) BSA in DPBS
containing 0.1% TweenH 20 (PBST) for 1 hour at room
temperature with gentle shaking. Primary antibodies (1:10,000
for RHAMM, 1:5000 for CD44 and b-actin, 1:500 for Hyal1 and
Hyal2) in 3% (w/v) BSA in PBST were incubated with the
membrane for 2.5 hours at room temperature with shaking. The
membrane was washed 3 times, 10 minutes each time, with PBST.
Secondary antibodies (1:5000 goat-a-rabbit HRP or 1:10,000
equine-a-mouse HRP) in 3% (w/v) BSA (for Hyal1, Hyal2, and b-
actin blots) or 3% (w/v) non-fat dried milk (for RHAMM and
CD44 blots) were incubated with the membrane for 1 hour at
room temperature with shaking. The membrane was washed 3
times, 10 minutes each time, with PBST. SupersignalH West Dura
Extended Duration Substrate (Thermo Scientific) was prepared as
directed and applied to the membrane for 5 minutes at room
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temperature with shaking. The blot was exposed using BioMax
Light Film (Kodak, Rochester, NY) and developed in an SRX-
101A developer (Konica Minolta Medical & Graphic Inc, Tokyo,
Japan). PC-3 cell lysate (50 mg) was used as a positive control for
CD44 westerns.
Immunostaining Protocol
Cells grown on 2D were cultured in an 8 well Lab-Tek II
Chambered Coverglass (Nalge Nunc, Naperville, IL). The
medium was removed and chambers were washed 2 times with
DPBS. Cells were fixed for 10 minutes in 4% (v/v) para-
formaldehyde (PFA) (Electron Microscopy Sciences, Hatfield, PA)
in ddH2O. Excess PFA was removed and the chambers were
washed twice with DPBS. Triton X-100 in DPBS (0.2% (v/v)) was
prepared and applied to chambers for 10 minutes. Excess Triton
X-100 solution was removed and chambers were washed twice
with DPBS. Cultures were blocked in 3% (w/v) BSA in DPBS at
4uC overnight. Cells were incubated with 1:1000 (v/v) solution of
RHAMM or CD44 primary antibodies in 3% BSA at 4uC
overnight. A 1:1000 (v/v) solution of Draq5 (Biostatus Limited,
Leicestershire, UK) in DPBS was applied for 10 minutes at room
temperature. Chambers again were washed with DPBS and Gel/
MountTM (Biomeda, Foster City, CA) was added to chambers to
prevent photobleaching. Cells were visualized using confocal
microscopy on a Zeiss LSM 510 VIS (Carl Zeiss, Maple Grove,
MN).
Cells in 3D were cultured in 24-well plates as described above.
Cell clusters were gently removed from the hydrogel using
a micropipette. Clusters were washed gently with 1 mL DPBS 2
times, quickly centrifuging to collect cell clusters each time.
Clusters were carefully resuspended in 4% (v/v) PFA and
transferred to an 8 well chambered coverglass. Cultures were
incubated at room temperature for 10 minutes. Once transferred
to the chambered coverglass, the same staining procedures were
used as employed for 2D culture. Extreme care was taken to retain
as many cell clusters as possible during each liquid removal step.
Cell Surface Biotinylation Assay
C4-2 cells were cultured in a T-75 flask to approximately 90%
confluency. Cells were released from the flask, suspended in T-
medium and counted. Cells were washed three times in ice-cold
PBS (pH 8.0, 5 mL). Cells were resuspended in ice-cold PBS
(pH 8.0) to a final concentration of 206106 cells/mL. Freshly
prepared, 10 mM sulfo-NHS-SS-biotin (80 ml) was added to the
cell mixture and the mixture was incubated at room temperature
for 30 minutes with shaking. 50 mM Tris (pH 8.0, 2 mL) was
added to deactivate the biotinylation reaction, and the cell pellet
was subsequently washed twice with PBS (pH 8.0, 2 mL). The
final PBS wash was removed completely from the cell pellet, and
RIPA buffer containing PI (500 ml) was applied to the cell pellet.
The lysis reaction was incubated on ice for one hour. The lysate
was cleared by centrifuging at 12,000 RPM for 10 minutes, after
which the supernatant was removed and stored at –20uC.
A BCA assay was performed on the biotinylated lysate as
described previously; approximately 1.5 mg of protein was
obtained. Avidin agarose (1 mL) was applied to a microcentrifuge
tube and the resin was settled by centrifuging 1 minute at 2000
RPM. The resin was washed three times with RIPA buffer
(500 ml). The lysate was applied to the resin and the mixture was
incubated on a tube rotator at 4uC overnight. The resin was settled
by centrifuging 1 minute at 2000 RPM and the unbound lysate
was removed. Unbound lysate (10 ml) was mixed with Laemmli
Sample Buffer containing 5% (v/v) bME (10 ml). The resin was
washed three times with RIPA containing PI (500 ml). Laemmli
Sample Buffer containing 5% bME (50 ml) was applied to the
beads. Laemmli-containing mixtures were boiled for 5 minutes,
then spun down at 13,000 RPM. The biotinylated pulldown and
unbound fraction were electrophoresed and transferred to
nitrocellulose as described previously. Bone metastatic PCa cell
(PC3) lysate (10 ml) mixed with Laemmli sample buffer containing
bME (10 ml) was included as a positive control for CD44
expression. Western blotting for CD44, RHAMM, and GAPDH
were performed as described under the ‘‘Western Blotting’’
section.
RHAMM Knockdown
C4-2 cells were maintained in antibiotic-free medium for three
days prior to transfection. Mixed 6 pmol/cm2 Stealth RNAiTM
siRHAMM duplex (GGCGUCUCCUCUAUGAAGAACUAUA
and UAUAGUUCUUCAUAGAGGAGACGCC) and 0.5 ml/
cm2 LipofectamineTM RNAiMAX in OptimemH I for RHAMM
knockdown or 6 pmol/cm2 low GC Stealth RNAiTM negative
control duplex and 0.5 ml/cm2 Lipofectamine in Optimem for
transfection control. Transfection mixtures were incubated for 15
minutes at room temperature before applying to cells. Trans-
fection reactions were incubated for six hours at 37uC and plates
were swirled gently every hour to mix transfection reagents.
The transfection mixture was aspirated from the cells, and cells
were washed with DPBS. Antibiotic free medium was applied to
the cells and transfected cells were incubated at 37uC overnight
before using for experiments. Efficacy of RHAMM knockdown
was assessed through Western blotting for RHAMM as described
under the ‘‘Western Blotting’’ section.
Hyaluronidase Activity Assay
HAase Activity was examined via substrate gel electrophoresis
[35,36]. Low molecular weight HA was dissolved overnight at
37uC in distilled water (0.17 mg/mL). This HA solution was used
in lieu of water in the preparation of a 12% (w/v) ProtoGelH
acrylamide gel (National Diagnostics, Cherry Hill, NJ). LNCaP,
C4, C4-2 and C4-2B lysates or 50 mg BTH were mixed with equal
volumes of Lamelli sample buffer (5% (v/v)) and loaded on the
HA-containing gel. The gel was electrophoresed using an X-Cell
SurelockTM electrophoresis cell and MOPS running buffer. The
gel then was removed from the cassette and washed for one hour
at room temperature in 3% (v/v) Triton X-100 in PBS. The gel
then was incubated in a formate-NaCl buffer (0.1 M Sodium
Formate and 0.15 M sodium chloride dissolved in distilled water,
pH 4.6) for 16–20 hours at 37uC. The gel was washed twice with
distilled water then incubated with a 0.5% (w/v) Alcian Blue in
3% (v/v) glacial acetic acid solution for one hour to detect the
presence of HA. The gel was washed three times for one hour each
with a 7% (v/v) acetic acid solution for destaining and fixation.
The gel then was washed twice with distilled water, and twice with
a 50% (v/v) methanol, 10% (v/v) glacial acetic acid solution. To
detect the presence of protein on the gel, it was then incubated
with a 0.25% (w/v) Coomassie brilliant blue in 9% (v/v) ethanol,
45.5% (v/v) glacial acetic acid for one hour. This was followed by
three one hour washes with the methanol/acetic acid washing
solution.
Treating Cultures with HAase Inhibitor
A solution of 125 mM DSC was prepared in 40% (v/v) DMSO
and filtered in a Steriflip filter (Millipore) to sterilize. DSC (3.33 or
10 ml of 125 mM) was added to 800 ml or 2.4 mL T-medium in 24
or 6 well plates, respectively, to a final concentration of 500 mM
DSC, the IC-50 value of this inhibitor [37]. An equal amount of
40% (v/v) DMSO was used as a vehicle control. Medium was
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changed every three days and fresh DSC or DMSO solution was
applied as described.
Trypan Blue Exclusion
The toxicity of DSC on PCa cells was determined using a trypan
blue exclusion assay. 600,000 cells were plated into 6 well plates
with T medium, 5% (v/v) FBS, 1% (v/v) PS (4 mL). After 24
hours of culture, the cultures were treated with DSC or vehicle
control as described previously. At three and six day timepoints,
medium was aspirated and cells were released with trypsin
(250 ml). Cells were pelleted, then resuspended in 500 uL T
medium. 50 uL of a 0.4% (w/v) solution of trypan blue in buffered
isotonic salt solution was added to each sample. The total number
of white (live) and blue (dead) cells was determined by counting on
a hemocytometer. The percentage of live cells was determined
from this data.
Statistical Analysis
Error bars on all figures display standard error of the mean
(SEM). Significance was determined using Student’s two sample
two-tailed t-tests with p,0.05 considered significant.
Results
Invadopodia and Cluster Formation in 3D HA Hydrogels
Invadopodia and cluster formation response to
motogenic factors. In initial experiments, we evaluated C4-2
cell morphology in the HA hydrogel cell culture system to
determine if differences could be seen in response to FBS used as
a motogenic factor to stimulate motility. Control cultures were
treated with TCMTM, a plant-based serum replacement to
maintain cell growth and viability, without the ability to promote
invasion and migration. While TCMTM treated C4-2 cells showed
a lower metabolic output compared to FBS, assessed by WST
assay, there was no significant difference in estimated cell counts
for cells growing in either condition at either three or six day
timepoints (see Table S1). We observed and quantified morphol-
ogy differences of cells in these gels as a measure of cell invasion
potential and migration ability.
As shown in Figure 1A, at both three and six day timepoints, the
TCMTM treated C4-2 cultures showed smaller, well-defined cell
clusters mostly devoid of invasive cellular processes (invadopodia).
In contrast, the FBS-treated cultures showed larger cell clusters
that appeared more uneven in shape. Remarkably, the FBS
treated clusters were regularly seen to be merging together and
displayed a considerable number of clearly evident invadopodia at
each timepoint. The inset of Figure 1A displays a magnified view
of these invadopodia structures. The cell clusters appeared larger
after six days than after three days for each treatment, but the
number of invadopodia was relatively constant between the two
timepoints.
Quantification of the number of invadopodia revealed that the
number of these structures was significantly higher (p,0.0001) for
FBS treatment than for TCMTM treatment at both three and six
day timepoints (Figure 1B). The number of invadopodia did not
increase for either treatment between the two timepoints.
Quantification of merging cluster percentage showed that FBS
treated C4-2 cell clusters were more likely to be merging
compared to TCMTM treated cells for both three and six day
timepoints (Figure 1C). Collectively, these results show that the
HA hydrogel invasion assay can be utilized to test the effects of
motogenic factors on PCa cell invasion. Importantly, because
TCMTM supports cell growth, these data suggest that the processes
of invadopodia formation and merging clusters are independent of
cell division.
Invadopodia and cluster formation in a PCa progression
model. Next, we evaluated the parameters of invadopodia
number and merging cluster percentage in the HA hydrogel for
PCa cells representing increasing disease progression. For this
study we compared highly aggressive, metastatic C4-2 cells to their
less aggressive LNCaP parent cell line. Similar metabolic activities
and cell counts were observed when comparing LNCaP and C4-2
cultures at three and six day timepoints (see Table S1). We
hypothesized that the differences in invadopodia number and/or
merging cluster percentage observed in Figure 1 also would be
present when comparing growth of LNCaP and C4-2 cells in the
HA hydrogels.
At both three and six days of culture in the HA hydrogel,
LNCaP cells grew in well-defined, irregularly shaped, grape-like
clusters (Figure 2A). Few invadopodia were observed projecting
from the LNCaP cell clusters. C4-2 cells showed a similar
morphology as described in Figure 1, growing in large, poorly-
defined, merging clusters with abundant numbers of invadopodia.
When quantified, the number of invadopodia was significantly
different (p,0.001) between LNCaP and C4-2 cell culture at both
timepoints (Figure 2B). The number of invadopodia did not differ
between the three and six day timepoints for either of the cell lines.
For both timepoints, C4-2 cultures showed a higher percentage of
merging clusters compared to LNCaP, although the difference was
more dramatic on day six than day three (Figure 2C). Therefore,
the HA hydrogel invasion assay can be utilized to compare
invasion among different cancer cell lines. Because LNCaP and
C4-2 cells show similar rates of cell growth, but different levels of
invadopodia and cluster convergence these results again demon-
strate that these behaviors are independent of cell division.
Comparison of HA Hydrogel to Soft Agar Gel
We suspected that the invadopodia and merging cluster
formation observed in the HA hydrogels was due in part to the
chemical make-up of the hydrogel, not simply its mechanical
properties or the process of being encapsulated in 3D. To test this,
we compared C4-2 cell growth in HA hydrogels to that in non-
physiologically relevant soft agar gels.
The rheological properties of the HA hydrogels were compared
to that of 0.3% agar in Figure 3 (B and C). At time zero, the HA
hydrogels had a higher G’ than G’’, suggesting that gelation
occurred once HAADH and HAALD were mixed. The elastic
modulus continued to increase, reaching a plateau value of
139621 Pa at 1 h. Conversely, the agar solution gelled to reach
a final elastic modulus of 4666 Pa. While the elastic modulus
provides a measure of gel stiffness, tan(d), defined as G’’/G’, is
a useful indicator of hydrogel damping properties [38]. Here, the
final tan(d) values for HA gels and the agar gels were similar
(0.0260.01 and 0.0260.00, respectively) and close to zero,
characteristic of elastic hydrogels. Overall, HA and agar gels
had similar dissipative properties although the former was slightly
stiffer than the latter.
In soft agar, C4-2 cells formed small cell clusters that appeared
to grow in size slightly between two and five days of culture
(Figure 3A). However, compared to HA hydrogel cultures, cells in
the soft agar formed smaller clusters. Merging clusters that send
out invadopodia were not observed. Therefore, the ability of the
cells to form these merging clusters and invadopodia appeared to
be prominent only when HA was used as the 3D matrix.
While both HA and agar gels are soft and elastic, it is important
to note that these gels differ in that the HA gel crosslinks covalently
while the agar gel crosslinks physically. The crosslinking method,
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Figure 1. Invadopodia and cluster merging in the HA hydrogel invasion assay depend on treatment with motogenic factors. Images
of C4-2 cells cultured for three or six days with either 2% TCMTM (control) or 5% FBS (motogenic factor) in the HA hydrogel invasion assay. Arrow and
inset show a magnified view of the image to better display invadopodia. Black scale bars represent 200 mm, white scale bar on inset represents
50 mm (A). Quantification for average number of invadopodia (B) or percent merging clusters (C) in each imaged field. Error bars = SEM, n = 3,
***p,0.001.
doi:10.1371/journal.pone.0050075.g001
Figure 2. Invadopodia and cluster merging in the HA hydrogel invasion assay depend on invasive capability. Images of LNCaP or C4-2
cells cultured for three or six days with 5% FBS in the HA hydrogel invasion assay. Scale bars represent 200 mm (A). Quantification for average number
of invadopodia (B) or percent merging clusters (C) for each imaged field. Error bars = SEM, n = 3, *p,0.05, ***p,0.001.
doi:10.1371/journal.pone.0050075.g002
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along with possible differences in porosity and stiffness, represent
additional variables between the two gels. While we cannot know if
any of these variables may account in part for the observed cell
behavior, it is clear that the HA gels provide context-specific
signals to the cells that the agar gels do not.
HA Receptor Expression in PCa Cells
To understand how PCa cells interact with the HA hydrogel to
form merging clusters and invadopodia within the invasion assay,
we investigated the expression of several classes of HA-interacting
proteins, starting with the HA receptors. Western blotting showed
that both common isoforms of RHAMM were expressed across
the LNCaP series, with lower expression by LNCaP cells
compared to the more aggressive cell lines (Figure 4A). CD44
expression was not detected in the LNCaP cell series (Figure 4B)
although it was expressed in the PC3 cell line used as a positive
control.
Because RHAMM is reportedly found to be bound to CD44 on
the cell surface, we were interested to see if RHAMM was present
on the cell surface where it could interact with the HA hydrogel in
the absence of CD44. To test this, we performed a cell-surface
biotinylation assay under non-permeabilizing conditions where
only proteins accessible on the cell surface would be labeled
(Figure 4C). The presence of RHAMM, but not CD44, in the
biotinylated, cell surface samples showed convincingly that
RHAMM was bound to the cell surface of C4-2 cells even in
the absence of CD44, and indicates that CD44 is not required for
cells to express RHAMM on their surfaces where it can engage
HA. GAPDH was used as a cytoplasmic control and its lack of
labeling confirmed that the cells used in these experiments were
not permeabilized and further that the column was washed
sufficiently, removing all traces of unbiotinylated, cytoplasmic
proteins.
RHAMM Expression and Localization in 3D vs. 2D
Next, we investigated the effects of 3D HA hydrogel culture on
RHAMM expression and localization. As shown by immunoflu-
orescence, C4-2 cells cultured on 2D (Figure 5A) have stronger
nuclear RHAMM localization compared to cells cultured in 3D
HA hydrogel (Figure 5B). To quantify this difference in
localization, LSM imaging software was used to measure the
pixel density of RHAMM staining in a single line across each cell’s
width (Figure 5C). The average RHAMM pixel density was
measured inside and outside the nucleus for each cell. The
compiled results are shown in Figure 5D. In 3D HA hydrogel
culture, nuclear RHAMM staining is less than 2D nuclear
RHAMM staining. After five days of culture, RHAMM expression
differences also were seen. C4-2 cultures in 2D showed less
Figure 3. Cells cultured in the HA hydrogel show differences in morphology compared to an agar gel of matched stiffness. Images of
C4-2 cells cultured for zero, two, or five days with 5% FBS in the HA hydrogel or in 0.3% LMP agar. Scale bars represent 200 mm (A). Average elastic
(G’) and loss (G’’) moduli across one hour time for HA hydrogel (B) or 0.3% LMP agar (C). Error bars = SEM, n = 3.
doi:10.1371/journal.pone.0050075.g003
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RHAMM expression when compared to those in 3D HA hydrogel
culture (Figure 5E).
RHAMM Knockdown
Because we found that the C4-2 cells were differentially
expressing and localizing RHAMM in response to 3D HA
hydrogel culture and that LNCaP cells expressed less RHAMM
than C4-2 cells, we hypothesized that RHAMM expression was
necessary for invadopodia and/or merging cluster formation in the
HA hydrogel invasion assay. To test this hypothesis, we utilized
a RHAMM knockdown approach on C4-2 cells.
RHAMM knockdown effects on 2D cell
morphology. Figure 6A shows that our siRHAMM application
was effective in lowering RHAMM expression in C4-2 cells
compared to control. The two-day timepoint shows a 93%
decrease in RHAMM expression, and the other timepoints show
similar knockdown levels. The decrease in RHAMM expression is
maintained for at least six days of culture. SiRHAMM treated C4-
2 cells showed similar rates of growth compared to control cultures
(data not shown).
When cultured on 2D and stained with phalloidin to visualize
the cytoskeleton, siRHAMM C4-2 cells showed a different
morphology compared to control cells (Figure 6B). SiRHAMM
cells exhibited longer cellular processes compared to control
(Figure 6C). The average number of processes per cell was
unchanged between the two treatments (data not shown).
RHAMM knockdown effects on invadapodia and cluster
formation in 3D. To determine if the siRHAMM phenotype
observed in 2D culture translated to differences in 3D culture, we
cultured C4-2 cells in the 3D HA hydrogel invasion assay.
Compared to control, siRHAMM treated cells showed no visible
difference in morphology in the HA hydrogel invasion assay at
either timepoint (Figure 7A). Both cultures showed large cell
clusters with numerous processes as described above for C4-2 cells
in 3D cultures. Quantification showed similar results. Both
invadopodia number (Figure 7B) and merging cluster percentage
(Figure 7C) were unchanged between siRHAMM and control
cultures.
HAase Expression in PCa Cells
After determining that RHAMM knockdown did not affect
invadopodia and cluster formation of C4-2 cells in the HA
hydrogel invasion assay, we investigated if another family of HA
interacting proteins, HAases, may be responsible. Western blot
analysis showed that cells of the LNCaP series express both Hyal1
and Hyal2 (Figure 8A). Hyal2 was present in conditioned medium
while Hyal1 was only weakly secreted from the cells. All cells of the
series appeared to express and secrete similar levels of both
HAases. To determine the activity of these HAases, a substrate gel
assay was performed. All cells in the series showed HAase activity
at similar levels as shown by the clear areas on the Alcian blue
stained gel (Figure 8B). Coomassie blue staining for total protein
confirmed that an equal amount of protein was added to each
lane.
Hyaluronidase Inhibition
To determine if HAase expression was necessary for invadopo-
dia and/or cluster formation in the HA hydrogel invasion assay,
we utilized a HAase inhibitor, DSC. When applied to C4-2 cells in
the HA hydrogel invasion assay at the IC-50 value of 500 mM,
DSC showed noticeably smaller, unbranched cell clusters on day
three compared to vehicle control, as well as a lack of invadopodia
(Figure 9A). On day six a lack of invadopodia and cluster
branching was still observed. Quantification showed a lower
number of invadopodia in DSC-treated cultures at both three and
six day timepoints (Figure 9B). Analysis of merging cluster
percentages showed lower values for DSC treated cells at both
timepoints as well (Figure 9C).
Figure 4. Cells of the LNCaP series express cell-surface RHAMM in the absence of CD44. Western blotting and densitometry for RHAMM
(A) and western blotting for CD44 (B) across the LNCaP series of cell lines with b-actin used as a load control. Cell surface biotinylation for RHAMM
and CD44 with GAPDH utilized as a cytoplasmic control (C). PC-3 lysate was used as a positive control for CD44, Error bars = SEM, n = 3, *p,0.05
compared to LNCaP.
doi:10.1371/journal.pone.0050075.g004
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To ensure that the observed differences in invadopodia and
merging cluster formation were not attributable to DSC toxicity to
the cells, we performed a trypan blue exclusion assay. This assay
tested C4-2 cell viability with 500 mM DSC at the three and six
day timepoints used for the HA hydrogel invasion assay. The
trypan blue assay showed similar levels of high cell viability
(.95%) compared to vehicle control for cells observed at both
timepoints (Figure 9D).
Discussion
In this report, we provided data showing that the 3D HA
hydrogel invasion assay provides an easily quantified, physiolog-
ically relevant method to study cancer invasion and the functions
of individual HA interacting proteins likely to be involved in
migration through HA-rich connective tissues. The quantifiable
parameters of invadopodia and merging cluster formation were
shown to be independent of cell number, and yielded low error
values allowing for the use of statistical tests of significance. We
suggest that this method could easily be modified to fit the unique
experimental needs for examination of a variety of invasive cancer
cells. While there is no doubt that there remain differences
between soft, HA-rich connective tissues and the 3D HA hydrogels
we use, this method offers a useful alternative to existing methods
for mechanistic studies of cell invasion. As the field progresses,
a deeper understanding of the mechanical properties and
composition of these tissues will inform the development of more
physiologically relevant hydrogels. Additionally, while understand-
ing of how the chemically modified HA compares to native HA is
somewhat limited, our data demonstrates that cells can interact
with the crosslinked HA composing the hydrogel by degrading and
binding it. How these interactions compare to interactions with
native HA is unknown, but remains an exciting area of discovery.
Using this HA hydrogel method, we tested our hypothesis that
the formation of invadopodia along with merging cluster
formation that we observed in the HA hydrogels correlated with
the ability of the PCa cells to interact with the hydrogel matrix by
virtue of their expression of functional HA interacting proteins.
Although it has been examined in several studies, the expression
and function of the HA receptor, CD44, in prostate cancer
invasion and in the LNCaP series of cell lines has failed to lead to
general consensus. Some groups have reported a lack of CD44
mRNA and/or protein expression in these cell lines [39,40] while
others have found the receptor expressed as both mRNA and
protein under certain conditions [41,42]. Under the conditions
wherein this work was performed, cells in 3D hydrogels actively
moved through HA matrices while lacking expression of CD44,
hence, other HA interacting proteins almost certainly were
involved.
The alternative HA receptor, RHAMM/CD168, was an
intriguing candidate because of its foundational role in cell
motility through G protein dependent pathways [43,44]. Unlike
CD44, RHAMM was expressed in the LNCaP series cells growing
in 3D hydrogels, and correlated with their ability to mimic
prostate cancer progression. RHAMM expression levels were
lower in LNCaP cells than the other, more aggressive and motile
cells of the series. Interestingly, the expression of the higher
molecular weight RHAMM isoform decreased as the cells became
Figure 5. HA hydrogel culture changes expression and localizes RHAMM to the cell surface. C4-2 cells with 5% FBS on 2D (A) or in 3D HA
hydrogel for 3 days (B) immunostained for RHAMM (green) and nuclei (blue). Arrows indicate differences in nuclear RHAMM between the two culture
conditions. A quantification method was utilized that measured RHAMM staining intensity across a single line both inside and outside of the nucleus
(C). Arrows indicate marked points to average staining intensity between and outside of as depicted in the chart to the right. Results of the
quantification method show nuclear and cytoplasmic or membrane (cyto/mem)-bound RHAMM for both culture conditions (D). Western blotting for
RHAMM expression after five days of 2D or 3D culture with b-actin used as a load control (E).
doi:10.1371/journal.pone.0050075.g005
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more aggressive, while the opposite was observed for the lower
molecular weight isoform. This pattern has been associated
previously with poor prognosis in multiple myeloma patients
[45] and may be applicable for prostate cancer as well. If so,
RHAMM isoform profiling may one day prove to be a useful new
method of risk assessment for prostate cancer patients.
The RHAMM expression data, combined with the data
showing lower amounts of invadopodia and merging cluster
formation in LNCaP cells compared with C4-2, led us to wonder if
RHAMM expression may be a driving factor behind motility in
the LNCaP series. However, for RHAMM to interact with the HA
hydrogel matrix, it would need to be on the cell surface, and
RHAMM has been thought to be sequestered on the cell surface
by binding to the surface receptor for HA, CD44 [11]. Without
CD44 expression, it was unclear if RHAMM could still be
localized on the cell surface. Using a cell surface biotinylation
assay, we showed for the first time that RHAMM could be
presented on the cell surface in the absence of CD44. This finding
suggests many new questions. If not CD44, to what membrane
moiety is RHAMM binding? Does cell surface RHAMM mediate
different cellular functions when it is bound to CD44 in
comparison to when it is free or bound to other moieties? Can
RHAMM bind directly to the cell surface of some cancer cells?
Further research beyond the scope of this study is necessary to
answer these important questions.
To begin investigating if expression of RHAMM allows the C4-
2 cells to functionally interact with the components of the HA
hydrogel, we examined RHAMM expression and localization in
3D vs. 2D culture. We found that RHAMM was localized
predominantly in the nucleus of cells grown in 2D, but a larger
pool was found in the cytoplasm or membrane in 3D culture. This
redistribution may reflect RHAMM translocalization from the
Figure 6. RHAMM knockdown C4-2 cells show longer cellular processes on 2D compared to control. RHAMM Western blotting for
siRHAMM or low GC control transfected C4-2 cells across six days of culture with b-actin used as a load control (A). Fluorescent staining of siRHAMM
or low GC control transfected cells at day 2 on 2D for F-actin (green) and nuclei (blue) (B). Quantification of average process length for all cellular
processes within the imaged field (C). Error bars = SEM, n = 3, *p,0.05.
doi:10.1371/journal.pone.0050075.g006
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nucleus to the cytoplasm or membrane in response to the HA
present in the cells’ microenvironment or it may reflect a direct
transport of newly synthesized RHAMM to the cell surface in cells
grown in HA-rich 3D hydrogels. Supporting this, RHAMM
expression in 3D culture was significantly higher (p = 0.013) than
in 2D culture at day 5. These increases in RHAMM expression
Figure 7. RHAMM knockdown C4-2 cells in 3D HA hydrogel invasion assay show no differences compared to control. Images of
siRHAMM or low GC control transfected C4-2 cells cultured for two or five days with 5% FBS in the HA hydrogel invasion assay. Scale bars represent
200 mm (A). Quantification for average number of invadopodia (B) or percent merging clusters (C) in each imaged field. Error bars = SEM and n= 3.
doi:10.1371/journal.pone.0050075.g007
Figure 8. Cells of the LNCaP series show similar levels of HAase expression, secretion, and activity. Western blotting for Hyal1, Hyal2,
and b-actin as a load control across the LNCaP cell series and for LNCaP and C4-2 conditioned medium (CM) (A). Hyaluronidase substrate gel activity
assay for LNCaP series cell lysates and 50 mg BTH (B). Alcian blue stains HA (clear areas indicate HAase activity), Coomassie stain shows total protein as
a load control. Clear arrows indicate major clear zones, black arrows indicate protein bands suitable for load controls, MW=molecular weight marker
in kDa.
doi:10.1371/journal.pone.0050075.g008
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and cell surface and/or cytoplasmic localization also may lead to
increased activation of downstream signaling pathways associated
with motility [46]. Additionally, this data suggests that the
chemical modifications did not compromise the biological
activities of the HA comprising the hydrogel.
With the previous suggestion that RHAMM expression is
related to PCa aggression [14], and our new data that PCa cells
appear to be interacting with the hydrogel through changes in
RHAMM expression and localization, we hypothesized that
RHAMM expression was a driving factor behind invadopodia
formation and the increases in numbers of merging clusters. To
test this notion, we utilized siRNA knockdown methods. On 2D,
siRHAMM knockdown C4-2 cells produced some long, straight
cellular processes evident when compared to control transfectants.
However, in 3D, siRHAMM C4-2 cells did not show any
differences in numbers of invadopodia or in merging cluster
formation when compared to control transfected cells. Therefore,
the idea that RHAMM was a sole driving factor behind formation
of cellular processes was not supported by the knockdown data.
Thus, while our data does suggest that RHAMM expression plays
a role in PCa progression and metastasis and perhaps in risk
assessment, a decrease in RHAMM expression does not appear to
prevent stromal invasion by C4-2 cells. For this reason, de-
velopment of RHAMM targeted therapies seems unlikely to be
useful for prevention of prostate cancer metastases.
Next, we investigated what role, if any, HAases play in PCa
stromal invasion. HAases were expressed, secreted, and activated
at similar levels at all stages of progression the cell lines
represented. This suggests that even locally advanced prostate
cancers, as represented by LNCaP cells, already have activated
HAases that can assist in migration through HA-rich connective
tissues. This data indicates that HA degradation by HAases may
be as important in the development of early metastatic potential of
a tumor as it is in the later stages of metastasis. Previous studies
have shown that HAase secretion is 10 fold higher in PCa cells
compared to both normal adult prostate and benign prostatic
Figure 9. Invadopodia and cluster merging in the HA hydrogels depend on HAase activity. Images of C4-2 cells cultured for three or six
days with 5% FBS and either 500 mM DSC or vehicle control in the HA hydrogel. Scale bars represent 200 mm (A). Quantification for average number
of invadopodia (B) or percent merging clusters (C) in each imaged field. Trypan blue exclusion assay to test C4-2 cell viability at three and six days
with either 500 mM DSC or vehicle control (D). Error bars = SEM, n = 3, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0050075.g009
Prostate Cancer Invadopodia in 3D HA Hydrogels
PLOS ONE | www.plosone.org 12 November 2012 | Volume 7 | Issue 11 | e50075
hyperplasia [47]. Therefore, along with HAase, other acquired
properties affecting invadopodia and merging cluster formation
must account for the differences that we observed between LNCaP
and C4-2 cells grown in 3D hydrogels.
To test the need for active HAase in prostate cancer cell motility
in 3D HA-rich hydrogels, we utilized a HAase inhibitor, DSC, and
C4-2 cells treated at its IC-50 concentration of 500 mM [22,37].
DSC treatment decreased both the number of invadopodia and
the extent of cluster convergence seen in the HA hydrogels when
compared to vehicle-treated controls. These results suggest that
HAase activity is necessary, but not sufficient, for PCa cells to
acquire the ability to invade HA-rich connective tissue stroma.
Invadopodia are formed through a combination of both
production of degradative enzymes and activation of motility
promoting proteins [48]. The degradative enzymes clear the
matrix surrounding the cells and the motility promoting proteins,
such as Rho GTPases, encourage actin reorganization allowing
the cell to put forth the invadopodium [49]. We show that HAases
can aid in the development of invadopodia through their role as
a degradative enzyme. Interestingly, Na2+/H+ exchanger 1
(NHE1) is localized to invadopodia, acidifying the invadopodial
space [50]. NHE1 activates hyaluronidases by lowering the pH to
an optimal level [51]. Another contributing factor could be Rho
GTPase activation. C4-2 cells have higher levels of Rac1-GTP
compared to LNCaP cells [52]. Rac1 contributes to cell migration
and invadopodia formation [49,53].
Compelling arguments can be made suggesting Hyal1, Hyal2,
or a combination of the two enzymes, act as driving force(s) behind
PCa stromal invasion. Hyal1 has been most strongly implicated in
the metastasis of several cancer types, including PCa [54]. Also, as
an acid-active HAase, Hyal1 activation may explain the function
NHE1 plays when localized to invadopodia [10,50]. On the other
hand, Hyal2 is found on the cell surface where it interacts with HA
in the microenvironment. Additionally, Hyal2 interacts with HA
receptors, also possibly contributing to stromal invasion [51].
Further research is needed to determine which HAase(s) is the
principle player in PCa invasion and metastasis.
Taken together, our results suggest that DSC, and other HAase
inhibitors, may be effective in preventing stromal invasion by PCa
cells, even early in the course of locally invasive disease. In
combination with other interventions, DSC or other HAase
inhibitors, such as ascorbic acid derivatives or alkyl gallates, could
be incorporated into treatment regima for PCa patients to help
prevent tissue invasion and metastasis. DSC is currently FDA
approved for asthma and allergy treatment, making it an attractive
candidate for further pre-clinical study [24,25].
Conclusions
Here, we describe the development and use of a novel 3D HA
hydrogel system that can be used to study aspects of invasion,
including formation of invadopodia. This assay provides a more
typical microenvironment for PCa cells that have metastasized to
the bone marrow or other HA-rich connective tissues. Invasion in
this assay can be quantified by counting the number of
invadopodia and merging cell clusters. Invasion also depends on
the ability of the PCa cells to interact with the HA within the
hydrogel matrix. Knockdown of RHAMM expression did not
affect invadopodia or merging cluster formation, while inhibition
of HAase activity decreased both invadopodia and merging cluster
numbers. HAase expression and activity are necessary but not
sufficient for PCa cell invasion in the HA hydrogel. HAases may
play an essential role in PCa invasion through HA-rich connective
tissues, such as the bone marrow. Therefore, HAase inhibitors are
attractive candidates for drugs to prevent PCa invasion and
metastasis even early in disease progression.
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